Insider trade

An2 Therapeutics (ANTX): Director bought ~$78K

Robin Shane Readnour, Director at An2 Therapeutics, bought ~$78K of An2 Therapeutics shares.

~$78K
Approx. value · 75K sh @ $1.04
490K
Holds after · shares reported
Traded
Nov 19, 2024
Filed
Nov 21, 2024

What stands out in this filing

  • The purchase added 18.1% to the shares this insider held before it; the filing reports 489,788 shares, held indirectly afterwards.
  • 75,000 shares at an average of $1.04 each, as reported on the form.
  • No other open-market purchase by this insider in 13 months of filings.
  • 2 other insiders at ANTX also bought in the open market within 30 days.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 18, 2024Insider · 2 peopleInsiders: 2 purchases (~$70K)
  2. Nov 19, 2024 · this disclosureInsiderDirector purchased ~$78K of ANTX shares in the open market

What came next

  1. Nov 19, 2024Insider · 2 peopleInsiders: 2 purchases (~$83K)
  2. Nov 20, 2024Insider · 1 personInsiders: 2 purchases (~$58K)
  3. Nov 26, 2024Insider · 1 personInsiders: 2 purchases (~$35K)
  4. Nov 27, 2024Insider · 2 peopleInsiders: 3 purchases (~$74K)
  5. Dec 6, 2024Insider · 1 personInsiders: 2 purchases (~$28K)
  6. Dec 9, 2024Insider · 1 personInsiders: 2 purchases (~$44K)
  7. Dec 10, 2024Insider · 1 personInsiders: 2 purchases (~$15K)
  8. Jan 3, 2025Insider · 4 peopleInsiders: 4 sales (~$24K)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for An2 Therapeutics

For An2 Therapeutics, OQRO holds 9 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ANTX page.

Other recent filings by Robin Shane Readnour, Director

The full history of Robin Shane Readnour, Director is on the profile page.

How this filing works

Explore the data

Common questions

Which An2 Therapeutics (ANTX) insider traded, and how much?

Robin Shane Readnour, Director at An2 Therapeutics, bought ~$78K of An2 Therapeutics shares. 75K shares at $1.04, open market.

When did it happen, and when was it made public?

Traded: Nov 19, 2024. Filed: Nov 21, 2024. That is 2 days between the two dates.

What stands out in this filing?

The purchase added 18.1% to the shares this insider held before it; the filing reports 489,788 shares, held indirectly afterwards. 75,000 shares at an average of $1.04 each, as reported on the form. No other open-market purchase by this insider in 13 months of filings.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about An2 Therapeutics recently?

For An2 Therapeutics, OQRO holds 9 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the ANTX page.

Does this mean ANTX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at An2 Therapeutics

Everything OQRO holds on this company is on its ANTX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data